amsacrine has been researched along with Cancer of Pharynx in 1 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
Excerpt | Relevance | Reference |
---|---|---|
"Although only a few patients with head and neck cancer have been included in broad phase II studies, several responses have been reported, but detailed data concerning responders are lacking." | 2.68 | A two-step reevaluation of high-dose amsacrine for advanced carcinoma of the upper aerodigestive tract: a pilot phase II study. ( Jelic, S; Jovanovic, V; Kovcin, V; Milanovic, N; Nikolic-Tomasevic, Z; Tomasevic, Z; Vlajic, M, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jelic, S | 1 |
Nikolic-Tomasevic, Z | 1 |
Kovcin, V | 1 |
Milanovic, N | 1 |
Tomasevic, Z | 1 |
Jovanovic, V | 1 |
Vlajic, M | 1 |
1 trial available for amsacrine and Cancer of Pharynx
Article | Year |
---|---|
A two-step reevaluation of high-dose amsacrine for advanced carcinoma of the upper aerodigestive tract: a pilot phase II study.
Topics: Adult; Aged; Amsacrine; Antineoplastic Agents; Carcinoma, Squamous Cell; Disease-Free Survival; Dose | 1997 |